During JPM week, virtual care companies strut their plans to make GLP-1 drugs work harder, cost less
Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...
But, no matter what direction the general market takes, some stocks could stand out, potentially in 2025, and most ...
Zacks.com on MSN19h
NVO, VKTX Stocks Fall as Lilly's Zepbound, Mounjaro Sales Slow DownPopular obesity stocks fell on Tuesday after pharma giant Eli Lilly LLY lowered its sales guidance for full-year 2024 and announced disappointing preliminary fourth-quarter sales numbers. LLY’s ...
I recently learned of Eli Lilly & Co.’s (“Lilly”) recent lawsuit against FDA from Nicole DeFeudis, who interviewed me for her ...
Hosted on MSN21h
LLY Stock Down on Lower-Than-Expected Sales Guidance for Q4Eli Lilly and Company’s LLY shares declined 6.6% on Tuesday after the company lowered its sales guidance for full-year 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback